chemotherapy and concurrent EGFR inhibitor

Update on Evidence of CALGB 30406 Trial: Chemo/EGFR Inhibitor vs. EGFR Inhibitor Alone in Never-Smokers

Article

Just prior to ASCO, I mentioned the early results of the Cancer and Leurkemia Group B (CALGB -- Group A long-since defunct) 30406 trial.